PhaseBio Pharmaceuticals Inc: 8-K filed May 16, 2024

Form type

8-K

Filing date

May 16, 2024

Accession number

0001193125-24-140615

Filer

PhaseBio Pharmaceuticals Inc (CIK 1169245)